Roche launches antibody to identify PRAME protein expression

Create PDF

January 2023—Roche has launched its Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody to identify PRAME protein expression in tissue samples from patients who are suspected of having melanoma. Studies suggest that the detection of PRAME expression by immunohistochemistry complements findings from routinely used tests and enables more informed clinical decisions and improved patient outcomes, according to a company press release.

The PRAME (EPR20330) antibody is fully automated on all Roche BenchMark IHC and ISH instruments. It is validated for use using OptiView DAB IHC detection, UltraView Universal DAB detection, and UltraView Universal alkaline phosphatase red detection kits.